Sitrof Technologies, a provider of IT and document management solutions for the life sciences industry, announced that EMC has certified its drug safety intake automation solution – Sitrof Safety Capture.
Working in conjunction with Oracle Argus Safety, Sitrof Safety Capture improves a life sciences company's end-to-end pharmacovigilance (Phv) program by providing a holistic view of product stewardship-from clinical trials through post-marketing surveillance. Safety Capture transforms unstructured adverse event (AE) source documentation into easily searchable digital records, and automatically creates entries in the Argus Intake Worklist.
Benefits of Sitrof Safety Capture include:
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Merck Launches Phase III Trials of Once-Monthly Oral HIV PrEP Candidate MK-8527
July 14th 2025In the new EXPrESSIVE clinical trial program, Merck will evaluate MK-8527, a once-monthly, oral PrEP therapy, in populations at high risk of HIV-1 infection, including adolescent girls and women in sub-Saharan Africa.
Baxdrostat Shows Significant Blood Pressure Reduction in Phase III BaxHTN Trial
July 14th 2025In the BaxHTN Phase III study, AstraZeneca’s baxdrostat demonstrated statistically significant and clinically meaningful reductions in systolic blood pressure in patients with uncontrolled or treatment-resistant hypertension.